-
Jun 12 |
Diagnostics World | The International Myeloma Foundation's Black Swan Research Initiative is changing how multiple myeloma is detected, monitored, and managed. From single-cell detection technologies to population-scale screening programs, these advances are setting new standards for precision oncology diagnostics.
More
-
Jun 11 |
Diagnostics World | After the human genome was sequenced in 2003, expectations were high that it would drive direct and immediate benefits for the everyday healthcare of the general population. While genomics has fundamentally altered the clinical pathways for individuals with rare diseases and cancer, it has yet to become part of routine clinical practice.
More
-
Jun 10 |
Diagnostics World | Endometriosis occurs when tissue similar to the lining of the uterus grows outside of the uterus. The condition is painful, can impede fertility, and is difficult to diagnose. But a host of new tools seek to improve diagnostics and treatment for the condition.
More
-
Jun 05 |
Diagnostics World | PrecisionLife's new diagnostic approach is addressing a critical gap in complex chronic disease detection by targeting two genetically related conditions that share remarkable similarities. Long COVID and myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) are not just clinically similar—they're genetically connected, with researchers identifying nine genes common to both disease populations.
More
-
Jun 03 |
Diagnostics World | A new subtype of Castleman disease has been identified, the first such major discovery in 45 years. While it remains unclear how many individuals stand to benefit, this is a “hugely important” development for the proportion of patients who fit neither the “unicentric” nor “multicentric” criteria long used to describe the symptoms and disease experience.
More
-
May 30 |
Diagnostics World | iCAD announced a collaboration with Microsoft to include a set of AI-powered mammography solutions; Revvity has launched its new IDS i20 analytical random access platform from EUROIMMUN; and more.
More
-
May 29 |
Diagnostics World | iCAD announced a collaboration with Microsoft to include a set of AI-powered mammography solutions; Revvity has launched its new IDS i20 analytical random access platform from EUROIMMUN; and more.
More
-
May 27 |
Diagnostics World | Parallel developments in wearable sensors, microfluidics, and machine learning have enabled the first-time use of a “smart bandage” in 20 human patients with chronic wounds. The latest version of the bandage, referred to as iCares, was showcased in a new study where fresh fluid from injured tissue was continually sampled to classify wound severity and healing potential.
More
-
May 23 |
Diagnostics World | Diagnostic errors remain a persistent and costly challenge in healthcare worldwide, leading to significant patient harm and financial burden. Despite advances in medical technology and research, these errors—missed, delayed, or incorrect diagnoses—cause thousands of preventable deaths and billions in healthcare costs each year.
More
-
May 16 |
Diagnostics World | Genomics has led to phenomenal scientific and medical advances over the last several decades, especially in cancer care. This progress can be seen not only in personalized therapies and drug development, but also in the ability to use biomarkers to identify the right drug for the right patient at the right time.
More
-
Jun 12 |
Survey of 360 senior professionals finds modernization is key to overcoming longstanding industry challenges.
More
-
Jun 11 |
Echosens and Boehringer Ingelheim have expanded their long-standing partnership to accelerate progress in MASH diagnosis and care.
More
-
Jun 05 |
More
-
Jun 05 |
CluePoints, the premier sponsor of RBQMLive and provider of leading statistical and AI-driven software solutions, has announced the full agenda and expert speaker line up for the 4th annual, award-winning event, RBQMLive.
More
-
Jun 03 |
4D Path, a company dedicated to personalizing cancer care through its unprecedented approach to predicting tumor response, unveiled groundbreaking findings at the American Society of Clinical Oncology (ASCO) 2025 Annual Meeting, revealing the first predictive biomarker of its kind for breast cancer patients traditionally considered unlikely to respond to treatment.
More
-
May 30 |
More
-
May 29 |
4D Path, a company dedicated to personalizing cancer care through its unprecedented approach to predicting tumor response, today announced that the company will present new clinical data at the 2025 American Society of Clinical Oncology (ASCO) Annual Meeting from May 30–June 3 in Chicago, IL.
More
-
May 28 |
More
-
May 28 |
AMP announced the release of a three-part series of papers on core bioinformatics capabilities for professionals in clinical molecular diagnostic labs.
More
-
May 21 |
Growth in dedicated sample stability facilities at Tramore (Ireland) site to meet demand for flexible, regulatory-compliant storage solutions
More
View more articles